XML 15 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Ordinary Shares
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total
Beginning balance at Dec. 31, 2022 $ 387 $ 601,105 $ 387 $ (331,096) $ 270,783
Beginning balance (in shares) at Dec. 31, 2022 29,873,893        
Increase (decrease) in shareholders' equity (deficit)          
Issuance of ADSs upon exercise of share options   1     1
Issuance of ADSs upon exercise of share options (in shares) 877        
Issuance of ADSs and non-voting ordinary shares, net of commissions and offering expenses $ 1 2,715     2,716
Issuance of ADSs and non-voting ordinary shares, net of commissions and offering expenses (in shares) 100,000        
Issuance of ADSs upon settlement of restricted share units $ 1       1
Issuance of ADSs upon settlement of restricted share units (in shares) 56,988        
Share-based compensation expense   9,042     9,042
Foreign currency translation adjustment     (316)   (316)
Net Income (Loss)       (39,064) (39,064)
Ending balance at Mar. 31, 2023 $ 389 612,863 71 (370,160) 243,163
Ending balance (in shares) at Mar. 31, 2023 30,031,758        
Beginning balance at Dec. 31, 2022 $ 387 601,105 387 (331,096) 270,783
Beginning balance (in shares) at Dec. 31, 2022 29,873,893        
Increase (decrease) in shareholders' equity (deficit)          
Foreign currency translation adjustment         2,498
Net Income (Loss)         (131,565)
Ending balance at Sep. 30, 2023 $ 550 875,248 2,885 (462,661) 416,022
Ending balance (in shares) at Sep. 30, 2023 42,384,799        
Beginning balance at Mar. 31, 2023 $ 389 612,863 71 (370,160) 243,163
Beginning balance (in shares) at Mar. 31, 2023 30,031,758        
Increase (decrease) in shareholders' equity (deficit)          
Issuance of ADSs upon exercise of share options   165     165
Issuance of ADSs upon exercise of share options (in shares) 12,389        
Issuance of ADSs and non-voting ordinary shares, net of commissions and offering expenses $ 7 12,120     12,127
Issuance of ADSs and non-voting ordinary shares, net of commissions and offering expenses (in shares) 520,000        
Issuance of ADSs upon settlement of restricted share units (in shares) 21,793        
Share-based compensation expense   8,193     8,193
Foreign currency translation adjustment     (948)   (948)
Net Income (Loss)       (42,603) (42,603)
Ending balance at Jun. 30, 2023 $ 396 633,341 (877) (412,763) 220,097
Ending balance (in shares) at Jun. 30, 2023 30,585,940        
Increase (decrease) in shareholders' equity (deficit)          
Issuance of ADSs upon exercise of share options   139     139
Issuance of ADSs upon exercise of share options (in shares) 13,296        
Issuance of ADSs and non-voting ordinary shares, net of commissions and offering expenses $ 154 234,338     234,492
Issuance of ADSs and non-voting ordinary shares, net of commissions and offering expenses (in shares) 11,764,706        
Issuance of ADSs upon settlement of restricted share units (in shares) 20,857        
Share-based compensation expense   7,430     7,430
Foreign currency translation adjustment     3,762   3,762
Net Income (Loss)       (49,898) (49,898)
Ending balance at Sep. 30, 2023 $ 550 875,248 2,885 (462,661) 416,022
Ending balance (in shares) at Sep. 30, 2023 42,384,799        
Beginning balance at Dec. 31, 2023 $ 550 883,446 (1,304) (511,760) $ 370,932
Beginning balance (in shares) at Dec. 31, 2023 42,431,766       42,431,766
Increase (decrease) in shareholders' equity (deficit)          
Issuance of ADSs upon exercise of share options $ 2 1,868     $ 1,870
Issuance of ADSs upon exercise of share options (in shares) 133,735        
Issuance of ADSs upon settlement of restricted share units $ 1       1
Issuance of ADSs upon settlement of restricted share units (in shares) 67,096        
Share-based compensation expense   9,282     9,282
Foreign currency translation adjustment     526   526
Net Income (Loss)       (26,563) (26,563)
Ending balance at Mar. 31, 2024 $ 553 894,596 (778) (538,323) 356,048
Ending balance (in shares) at Mar. 31, 2024 42,632,597        
Beginning balance at Dec. 31, 2023 $ 550 883,446 (1,304) (511,760) $ 370,932
Beginning balance (in shares) at Dec. 31, 2023 42,431,766       42,431,766
Increase (decrease) in shareholders' equity (deficit)          
Foreign currency translation adjustment         $ (1,881)
Net Income (Loss)         (117,177)
Ending balance at Sep. 30, 2024 $ 890 1,462,264 (3,185) (628,937) $ 831,032
Ending balance (in shares) at Sep. 30, 2024 69,015,971       69,015,971
Beginning balance at Mar. 31, 2024 $ 553 894,596 (778) (538,323) $ 356,048
Beginning balance (in shares) at Mar. 31, 2024 42,632,597        
Increase (decrease) in shareholders' equity (deficit)          
Issuance of ADSs upon exercise of share options $ 5 4,495     4,500
Issuance of ADSs upon exercise of share options (in shares) 351,099        
Issuance of ADSs and non-voting ordinary shares, net of commissions and offering expenses $ 331 543,796     544,127
Issuance of ADSs and non-voting ordinary shares, net of commissions and offering expenses (in shares) 25,933,706        
Issuance of ADSs upon settlement of restricted share units (in shares) 23,840        
Share-based compensation expense   9,264     9,264
Foreign currency translation adjustment     (314)   (314)
Net Income (Loss)       (39,812) (39,812)
Ending balance at Jun. 30, 2024 $ 889 1,452,151 (1,092) (578,135) 873,813
Ending balance (in shares) at Jun. 30, 2024 68,941,242        
Increase (decrease) in shareholders' equity (deficit)          
Issuance of ADSs upon exercise of share options $ 1 911     912
Issuance of ADSs upon exercise of share options (in shares) 50,866        
Issuance of ADSs upon settlement of restricted share units (in shares) 23,863        
Share-based compensation expense   9,202     9,202
Foreign currency translation adjustment     (2,093)   (2,093)
Net Income (Loss)       (50,802) (50,802)
Ending balance at Sep. 30, 2024 $ 890 $ 1,462,264 $ (3,185) $ (628,937) $ 831,032
Ending balance (in shares) at Sep. 30, 2024 69,015,971       69,015,971